James P. Daugherty, MD — Muscle Shoals, Alabama

James P. Daugherty, MD is a clinical research site located in Muscle Shoals, Alabama, United States 35661.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

James P. Daugherty, MD has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Non-Small Cell Lung.

Sponsors: Point Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Muscle Shoals

Browse all research sites in Alabama · View every site in Muscle Shoals

• Northwest Alabama Cancer Center
• Research Site
• GSK Investigational Site
• Northwest Alabama Cancer Center PC
• Novartis Investigative Site
• Terence T. Hart, MD
• Syed Research Consultants
• Sanofi-Aventis Investigational Site Number 840074
• Pfizer Investigational Site
• Amarin Investigational Site
• Investigational Site Number 840326
• Forest Investigative Site 1413

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for James P. Daugherty, MD?

James P. Daugherty, MD has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has James P. Daugherty, MD conducted?

James P. Daugherty, MD has 1 clinical trials on record. Their work covers Carcinoma, Non-Small Cell Lung.

Is James P. Daugherty, MD accredited by Crixeo Clinical Trials?

James P. Daugherty, MD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about James P. Daugherty, MD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.